Osprey Private Wealth LLC Raises Stock Holdings in Thermo Fisher Scientific Inc. $TMO

Osprey Private Wealth LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,537 shares of the medical research company’s stock after acquiring an additional 1,397 shares during the quarter. Thermo Fisher Scientific comprises approximately 2.9% of Osprey Private Wealth LLC’s investment portfolio, making the stock its 10th biggest holding. Osprey Private Wealth LLC’s holdings in Thermo Fisher Scientific were worth $10,095,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Conning Inc. increased its stake in Thermo Fisher Scientific by 8.5% during the 1st quarter. Conning Inc. now owns 10,822 shares of the medical research company’s stock worth $5,319,000 after purchasing an additional 852 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Thermo Fisher Scientific by 3.0% in the 1st quarter. Sequoia Financial Advisors LLC now owns 15,810 shares of the medical research company’s stock worth $7,771,000 after purchasing an additional 466 shares during the period. Ramsay Stattman Vela & Price Inc. increased its holdings in Thermo Fisher Scientific by 3.3% during the 1st quarter. Ramsay Stattman Vela & Price Inc. now owns 16,016 shares of the medical research company’s stock worth $7,872,000 after purchasing an additional 508 shares in the last quarter. Whipplewood Advisors LLC lifted its holdings in shares of Thermo Fisher Scientific by 41.3% in the first quarter. Whipplewood Advisors LLC now owns 421 shares of the medical research company’s stock valued at $207,000 after purchasing an additional 123 shares in the last quarter. Finally, Elevated Capital Advisors LLC boosted its position in shares of Thermo Fisher Scientific by 9.2% during the first quarter. Elevated Capital Advisors LLC now owns 1,209 shares of the medical research company’s stock worth $594,000 after buying an additional 102 shares during the period. 89.23% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific Stock Up 0.4%

Shares of NYSE TMO traded up $2.01 during trading hours on Friday, hitting $526.72. The company had a trading volume of 1,233,008 shares, compared to its average volume of 1,993,707. The stock has a market capitalization of $195.74 billion, a P/E ratio of 28.96, a price-to-earnings-growth ratio of 2.32 and a beta of 0.87. Thermo Fisher Scientific Inc. has a 1-year low of $403.36 and a 1-year high of $643.99. The firm’s 50 day moving average is $478.23 and its 200-day moving average is $516.44. The company has a quick ratio of 1.15, a current ratio of 1.53 and a debt-to-equity ratio of 0.77.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Thursday, April 23rd. The medical research company reported $5.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.25 by $0.19. Thermo Fisher Scientific had a net margin of 15.15% and a return on equity of 16.86%. The firm had revenue of $11.01 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the firm posted $5.15 earnings per share. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. On average, analysts expect that Thermo Fisher Scientific Inc. will post 24.84 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 15th. Thermo Fisher Scientific’s payout ratio is 10.34%.

Insider Transactions at Thermo Fisher Scientific

In other news, COO Gianluca Pettiti sold 400 shares of the firm’s stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $462.66, for a total value of $185,064.00. Following the completion of the sale, the chief operating officer directly owned 25,051 shares of the company’s stock, valued at $11,590,095.66. This trade represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on TMO shares. Barclays dropped their target price on Thermo Fisher Scientific from $650.00 to $625.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Wells Fargo & Company lowered their price objective on shares of Thermo Fisher Scientific from $675.00 to $615.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Evercore set a $570.00 target price on shares of Thermo Fisher Scientific in a report on Monday. Morgan Stanley reiterated an “overweight” rating and issued a $620.00 price target on shares of Thermo Fisher Scientific in a research note on Monday, April 27th. Finally, DZ Bank began coverage on shares of Thermo Fisher Scientific in a research note on Friday, March 27th. They set a “buy” rating and a $610.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $602.14.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.